Steadtrust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$676K Hold
11,732
0.34% 68
2026
Q1
$712K Hold
11,732
0.4% 62
2025
Q4
$633K Buy
+11,732
New +$564K 0.39% 71

Other funds holding BMY

Steadtrust's BMY Position: Q2 2026 in Review

Steadtrust held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 11,732 shares worth $676K. The position accounts for 0.34% of the portfolio, ranked #68.

Steadtrust first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $712K in Q1 2026. 2,503 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Steadtrust held 11,732 shares of Bristol-Myers Squibb worth $676K as of Q2 2026.
  • Steadtrust left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.34% of Steadtrust's portfolio in Q2 2026, its #68 holding.
  • Steadtrust first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Steadtrust's Bristol-Myers Squibb position peaked at $712K in Q1 2026.
  • 2,503 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Steadtrust's 13F filing for Q2 2026, filed 9 Jul 2026.